
201 - 500 employees
🏥 Healthcare
🧬 Biotechnology
💊 Pharmaceuticals
💰 $300M Post-IPO Equity - Xenon Pharmaceuticals on 2023-11
Healthcare • Biotechnology • Pharmaceuticals
Xenon Pharmaceuticals Inc. is a clinical-stage biotechnology company focused on neuroscience drug discovery and development. It leverages human genetics, ion-channel biology, and novel chemistries to create selective modulators of central and peripheral nervous system ion channels. Its lead late-stage investigational candidate, azetukalner, is being developed for epilepsy and depression. The company emphasizes patient-centered research, clinical trials, and support for people affected by neurological and psychiatric disorders.
🕒 July 16
National Account Director strategizing U.S. market access for Xenon's innovative products. Building relationships with commercial payers to enhance patient access and minimize hurdles.
🇺🇸 United States – Remote
💵 $236.7k - $260.2k / year
💰 $300M Post-IPO Equity - Xenon Pharmaceuticals on 2023-11
⏰ Full Time
🔴 Lead
👔 Director
🕒 July 13
National Account Director responsible for U.S. market access strategy and payer relationships at Xenon Pharmaceuticals. Collaborating across functions to ensure access to Azetukalner for epilepsy treatment.
🇺🇸 United States – Remote
💵 $236.7k - $260.2k / year
💰 $300M Post-IPO Equity - Xenon Pharmaceuticals on 2023-11
⏰ Full Time
🔴 Lead
🧑💼 Account Executive
🕒 June 26
Director responsible for commercial learning strategy and training programs at Xenon Pharmaceuticals. Focus on building field capability and supporting launch readiness.
🇺🇸 United States – Remote
💵 $224.5k - $245.5k / year
💰 $300M Post-IPO Equity - Xenon Pharmaceuticals on 2023-11
⏰ Full Time
🔴 Lead
👔 Director